Effectiveness and safety of treatments for new-onset, refractory and relapsed vitreoretinal lymphoma: protocol for a systematic review and network meta-analysis
Abstract Introduction Vitreoretinal lymphoma (VRL) is a rare intraocular malignancy. It has a poor prognosis because, despite a range of therapeutic approaches, central nervous system (CNS) lymphoma may arise at any stage. Because of the rarity of VRL, intervention studies that attempt to define optimal treatment, espe...